搜尋結果
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
Reuters· 1 日前, opens new tab to market its blockbuster obesity treatment drugs in India, the company's ...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters· 2 日前, opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months ...
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
Reuters· 2 日前Indian generic drugmaker Alembic Pharma reported a 17% rise in fourth-quarter profit on ...
Securitization limbers up for the oddball Olympics
Reuters· 3 日前Securitization might sound exotic. The idea of pooling millions of IOUs like car loans and ...
India's Dr Reddy's expects healthy products pipeline in North America for FY25
Reuters· 4 日前, opens new tab expects a healthy products pipeline in its key North American market in the fiscal year 2024-25, the generic ...
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
Reuters· 5 日前Indian generic drugmaker Lupin reported a smaller-than-expected rise in fourth-quarter profit on Monday, as higher raw material ...